PubRank

Yong Han Paik

Author PubWeight™ 49.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 2003 3.69
2 A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol 2012 2.43
3 [Extrapancreatic tumors in intraductal papillary mucinous neoplasm of the pancreas]. Korean J Gastroenterol 2009 1.48
4 Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol 2012 1.47
5 Prospective validation of P2/MS noninvasive index using complete blood counts for detecting oesophageal varices in B-viral cirrhosis. Liver Int 2010 1.46
6 Colorectal flat neoplasia. Dig Liver Dis 2003 1.43
7 N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice. J Gastroenterol Hepatol 2012 1.41
8 Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity. J Gastroenterol Hepatol 2004 1.39
9 Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci 2008 1.35
10 Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int 2010 1.25
11 Migration of fibrocytes in fibrogenic liver injury. Am J Pathol 2011 1.17
12 A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol 2010 1.15
13 Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model. Am J Gastroenterol 2011 1.14
14 How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B? J Clin Gastroenterol 2010 1.12
15 Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B. Hepatology 2010 1.11
16 Transitional features of histologic type of non-alcoholic fatty liver disease in Korean young men. J Gastroenterol Hepatol 2012 1.07
17 Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. Cancer 2005 1.06
18 PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection. Oncology 2007 1.04
19 Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. J Med Virol 2006 1.03
20 Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea. Eur J Gastroenterol Hepatol 2007 0.99
21 Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma. Clin Cancer Res 2006 0.98
22 Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis. Liver Int 2005 0.97
23 Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea. Medicine (Baltimore) 2016 0.95
24 A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients. Liver Int 2010 0.94
25 Small Hepatocellular Carcinoma: Radiofrequency Ablation versus Nonanatomic Resection--Propensity Score Analyses of Long-term Outcomes. Radiology 2015 0.93
26 Long-term survival after surgical resection for huge hepatocellular carcinoma: comparison with transarterial chemoembolization after propensity score matching. J Gastroenterol Hepatol 2014 0.92
27 Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant 2010 0.92
28 Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir. Antivir Ther 2009 0.89
29 Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Liver Int 2013 0.88
30 Comparison of usefulness of clinical diagnostic criteria for hepatocellular carcinoma in a hepatitis B endemic area. Clin Mol Hepatol 2012 0.84
31 A clinical predictor of varices and portal hypertensive gastropathy in patients with chronic liver disease. Clin Mol Hepatol 2012 0.84
32 The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma. Medicine (Baltimore) 2016 0.82
33 External validation of P2/MS and comparison with other simple non-invasive indices for predicting liver fibrosis in HBV-infected patients. Dig Dis Sci 2009 0.82
34 Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study. Clin Mol Hepatol 2013 0.79
35 Salvage chemotherapy with docetaxel and epirubicin for advanced/metastatic gastric cancer. Oncology 2008 0.78
36 [Protein expression profiles in a rat cirrhotic model induced by thioacetamide]. Korean J Hepatol 2006 0.78
37 Screening test data analysis for liver disease prediction model using growth curve. Biomed Pharmacother 2003 0.78
38 Repeated Hepatic Resection versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Hepatic Resection: A Propensity Score Matching Study. Radiology 2015 0.78
39 Clinical course of virologic breakthrough after emergence of YMDD mutations in HBeAg-positive chronic hepatitis B. Intervirology 2008 0.78
40 Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen-positive chronic hepatitis B patients. J Gastroenterol Hepatol 2014 0.77
41 Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea. Medicine (Baltimore) 2016 0.77
42 Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma. Anticancer Drugs 2008 0.76
43 Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in rats. Apoptosis 2013 0.76
44 [Clinical outcomes of systemic chemotherapy in hepatocellular carcinoma patients with multiple lung metastases]. Korean J Hepatol 2008 0.76
45 Toll-like receptor polymorphisms are not associated with liver cirrhosis in hepatitis B virus infected Korean patients. Hepatogastroenterology 2011 0.76
46 Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods. Medicine (Baltimore) 2016 0.75
47 Pegylated interferon and ribavirin in the retreatment of chronic hepatitis C in Korea. Gut Liver 2013 0.75
48 [Acute hepatitis A complicated with acute kidney injury]. Korean J Gastroenterol 2010 0.75
49 [Clinical features and prognostic factors of fulminant hepatic failure in Koreans]. Korean J Hepatol 2004 0.75
50 [Changes of ascites nitric oxide according to the treatment course in cirrhotic patients with spontaneous bacterial peritonitis]. Korean J Hepatol 2004 0.75
51 [Usefulness and safety of extracorporeal liver support therapy using MARSR for patients with liver failure: a preliminary report]. Korean J Gastroenterol 2009 0.75
52 [Type of electric currents used for standard endoscopic sphincterotomy does not determine the type of complications]. Korean J Gastroenterol 2004 0.75
53 [Natural history of HBeAg negative chronic hepatitis B virus infection: a cohort study]. Korean J Hepatol 2006 0.75
54 Clinical characteristics of acute hepatitis A complicated by acute kidney injury. Scand J Infect Dis 2011 0.75